Press

Hanover, MD, April 25, 2022 – Today the Society for Clinical Research Sites (SCRS) announced that Sanofi has made a commitment to become a funding sponsor of the SCRS Diversity Awareness Program. The program is aimed at developing a better understanding of the knowledge, expertise and best practices required for clinical research sites to meet the needs of an increasingly diverse population. Since its inception in 2017, the program has provided critical knowledge and solutions to aid sites in successfully engaging diverse patients in clinical trials.  “Sanofi is committed to enrolling patients in clinical trials who are representative of the people our medicines are intended to help. To help improve on diversity in clinical trials, we are implementing a number of steps, including the way we design our studies, the sites we recruit from, how we train investigators in referring patients for clinical trials, and engagement with community stakeholders. As such we are pleased to be a funding sponsor of the SCRS diversity awareness program,” commented Dietmar Berger, Chief Medical Officer, Global Head of Development at Sanofi. “Sanofi has been involved with SCRS for many years and has always prioritized the perspective of clinical research sites and patients,” said Diana Foster, SCRS VP of Strategy and Special Projects. “SCRS is privileged to have Sanofi included in supporting the SCRS Diversity Program and we look forward to our continued collaboration towards this vital initiative.” ### About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/ Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 x150

Michael Pierre Mary Lord Hanover, MD, April 13, 2022 – The Society for Clinical Research Sites (SCRS) today announced Michael Pierre, Senior Director of Systems Management at Meridian Clinical Research, and Mary Lord, Associate Director at Merck, have joined its Education Committee. The SCRS Education Committee provides guidance and oversight of all SCRS educational activities and identifies opportunities to provide additional training programs specifically for research sites. As Education Committee chairs, Pierre and Lord lead and facilitate the work of the group. “I have been part of SCRS since it began, and remain a strong supporter of its mission,” said Pierre. “I am looking forward to being a part of the Education Committee and providing quality and innovative content to SCRS members.” “I am humbled to join the Education Committee and excited about all that is possible in this space. Bringing informative content to the clinical research site community is something I am very passionate about,” commented Lord. Jimmy Bechtel, SCRS VP of Site Engagement, added, “SCRS is always looking for ways to provide more resources and best practices for our members and the global site community. We welcome Michael and Mary to the Education Committee and look forward to their insights on additional programs that support SCRS’ mission of ensuring site sustainability.” About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact:Marissa HillCommunications ManagerSociety for Clinical Research Sitescommunications@myscrs.org410.696.5080 x150

Hanover, MD, March 29, 2022 – Today the Society for Clinical Research Sites (SCRS) announced that Michele Cameron, BSN, MBA, CCRC, Director of Clinical Research at Clearwater Cardiovascular Consultants, has joined the organization’s Leadership Council. In this role, Cameron will join sites, sponsors, CROs and professional solution providers to help guide SCRS’ strategy to carry out its mission of unifying the voice of the global clinical research site community for greater site sustainability. “As the 2021 recipient of the Christine K. Pierre Site Impact Award, Michele Cameron is clearly a strong advocate for the SCRS mission and the work we do on behalf of the sites. The SCRS Leadership Council helps determine strategic initiatives for SCRS, and Michele’s site-focused expertise will be a valuable addition to this group,” commented Allyson Small, SCRS Chief Operating Officer. Cameron added, “I am honored to have the opportunity to work with the SCRS Leadership Council. My goal will be to contribute my experience and knowledge gained through working as a Project Director for a large sponsor and currently as a Site Director to broaden the understanding between sites and industry leaders in order to ‘find solutions through collaboration,’ a founding principle of SCRS founder, Christine Pierre.” ### About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 x150

Hanover, MD, March 22, 2022 – The Society for Clinical Research Sites (SCRS) is pleased to welcome Janssen Research & Development, LLC (Janssen) as an Oncology Spirit Partner. SCRS Oncology Spirit Partners serve on the SCRS Oncology Advisory Board with leadership roles in its Oncology Program and Strategic Working Groups. Through this strategic sponsorship, Janssen will have active involvement in the SCRS Oncology Program and the Global Oncology Site Solutions Summit, held annually in Austin, Texas, which brings research sites, sponsors, CROs, and solution providers together to learn and communicate solutions for more efficient oncology research. Janssen will also exhibit at the conference and host a Site Symposium to discuss changes affecting oncology research. “SCRS is proud to collaborate with Janssen as an Oncology Spirit Partner to support oncology research sites and patients they work with,” said Marcus Maleck, Director of Global Business Partnerships at SCRS. “We are excited for the SCRS Oncology program and the Global Oncology Site Solutions Summit.” ### About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

Hanover, MD, March 16, 2022 – Today the Society for Clinical Research Sites (SCRS) announced that Javara has joined the organization as a Global Impact Partner (GIP). Javara is a leading Integrated Research Organization (IRO) partnering with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. As a GIP, Javara will align with more than 50 sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally. Sean Soth, SCRS Senior Vice President of Strategy & Global Business Partnerships commented, “As an integrated research organization facilitating relationships with healthcare organizations and industry partners, Javara will provide a unique perspective to the SCRS Global Impact Partner program. SCRS is proud to initiate work with the Javara team and excited to apply their insights and thought leadership to support industry collaboration and site sustainability.” “At Javara we are working to fully realize the integration of clinical research with clinical care, ensuring patients have the opportunity to access clinical research as a care option through their trusted provider relationships. We are thrilled to partner with SCRS to bring forth new solutions to strengthen relationships and advance clinical research connectivity for both physicians and patients,” says Javara CEO Jennifer Byrne. About Javara Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. Our access to broad diverse patient populations through their trusted physician ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 x150

Hanover, MD, March 8, 2022 – Today, the Society for Clinical Research Sites (SCRS) announced a Global Impact Partnership with Aspen Insights, a data science and machine learning company focused on bringing innovation to the clinical research space. Aspen offers practice integrated and DCT research sites a means to dramatically increase enrollment rates through the use of its artificial intelligence, patient-matching platform, Aspen Forge, as well as its suite of professional services. As a Global Impact Partner (GIP), Aspen Insights will align with clinical research industry sponsors, CROs, and service providers that share an ongoing commitment to improve the quality of patient recruitment, clinical research site performance, and ultimately, site sustainability. Sean Soth, Senior Vice President of Strategy & Global Business Partnerships for SCRS, commented, “Data science applications and strategies will continue to inform innovation within clinical research.  Aspen Insights is working to solve some of clinical research’s most challenging recruitment obstacles through technology and consulting experience.  Aspen’s optimal goal is to bring innovative medical treatment to patients faster by streamlining the clinical research recruiting process, which supports the SCRS mission of creating sustainable sites. SCRS welcomes Aspen Insights to the GIP program and is eager to incorporate their feedback to develop more site-focused programming for efficient patient recruitment.” “We want to get Aspen Forge into the hands of researchers. There is no longer a need for anyone to manually sift through their patient records to find quality candidates”, says Aspen Insights’ CEO, Walter Storm. “Our platform unifies data across various EMRs and therapeutic areas to identify a larger, more qualified pool of study candidates in a fraction of the time compared to traditional methods.  We are confident that our technology solutions can speed up the clinical research recruitment process to the point where innovative medical treatments can remain low in cost and financially accessible to a greater, more diverse community of patients in need.” About Aspen Insights Headquartered in Fort Worth, Texas, Aspen Insights is a data science and artificial intelligence firm principally engaged in the research, design, development, and integration of healthcare analytics systems, products, and services. Aspen’s technology offerings enable sites to accurately predict enrollment numbers and quickly identify ideal trial candidates. With a demonstrated track record, Aspen has been able to assist sites in becoming leaders in enrollment performance across various therapeutic areas. Visit AspenInsights.com About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: SCRS Communications Society for Clinical Research Sites 410.696.5080 communications@myscrs.org

Hanover, MD, February 22, 2022 – The Society for Clinical Research Sites (SCRS) is pleased to announce that Mohammad Millwala, MBA, CPA, CEO of DM Clinical Research, has accepted a seat on its Leadership Council.  Established upon SCRS’ formation in 2012, the Leadership Council provides strategic guidance, policy decisions, and oversight for the organization’s programs. Members are selected based on their involvement with SCRS, executive experience in the clinical research industry, and capacity to aptly represent the interests of clinical research sites globally.  Millwala is the founder and CEO of DM Clinical Research. He has an MBA from Northeastern Illinois University and with his solid business background, founded DM Clinical Research in 2006. DM Clinical Research is the largest privately-owned clinical research network in the Houston area and has location in Pennsylvania, Illinois, and Michigan, providing the pharmaceutical industry a large and experienced group of physicians conducting well-orchestrated clinical trials and an immensely diverse participant population. SCRS Chief Operating Officer Allyson Small commented, “Mohammad has been an active member of SCRS since 2013 and his commitment to site sustainability and ensuring site voices are heard has been invaluable to SCRS’ mission. He is a valuable addition to the Leadership Council and we welcome his expertise as we work to address issues affecting clinical research sites.” Millwala added, “I am grateful for the opportunity to contribute to the SCRS Leadership Council and look forward to sharing my knowledge with other emerging leaders in the industry.” To see a list of current Leadership Council members, click here. About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 x150

Hanover, MD, February 17, 2022 – The Society for Clinical Research Sites (SCRS), the global trade organization dedicated to representing the interests of clinical research sites, today announced Vice Admiral Jerome Adams, MD, MPH, as a Keynote Speaker for its inaugural Diversity Site Solutions Summit on May 20, 2022 in Austin, Texas. Jerome Adams is the Chairman of the Board at Total Diversity Clinical Trial Management and Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th U.S. Surgeon General as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic. As the keynote speaker at the SCRS Diversity Site Solutions Summit, Adams will share knowledge of best practices for diverse patient engagement. The Summit will feature critical content as regulatory and sponsor directives require more mandatory inclusion of diverse populations in trials. Diana Foster, SCRS Diversity Awareness Program Lead commented, “SCRS is honored to have Jerome Adams as our keynote speaker for the first Diversity Site Solutions Summit. Adams’ expertise and advocacy for ensuring health equity for underrepresented populations will be instrumental to our program. We look forward to sharing solutions and best practices to establish more diverse representation in clinical trials.” “The reality of diversity enrollment and inclusion in clinical trials is upon us. We are beyond the ‘discussion’ and must operationalize and execute strategy to better serve all individuals eligible to participate in trials, not but a few,” Adams commented. Registration for the 2022 SCRS Diversity Site Solutions Summit is open now. Learn more and register for the Summit at diversitysitesolutionssummit.com. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/. Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 x150

Contact: Marissa Hill Society for Clinical Research Sites410.696.5080communications@myscrs.org Shawn Malloy media@curebase.com 315-882-5310 FOR IMMEDIATE RELEASE Hanover, MD, Feb. 7, 2022 – The Society for Clinical Research Sites (SCRS) announced today that Curebase, a company committed to democratizing access to clinical studies, has joined the organization as a Global Impact Partner (GIP). GIPs work closely with the SCRS Leadership Council as strategic partners that set key initiatives for SCRS to advance site performance and sustainability. Becoming a GIP demonstrates Curebase’s commitment to develop a comprehensive understanding of the needs of research sites and incorporate site feedback into the development of clinical research software. “Curebase is working to create a flexible decentralized solution for both patients and sites. Ensuring site voices are heard as the industry develops new solutions is critical. SCRS welcomes Curebase into the Global Impact Partner program and recognizes their commitment to strong site engagement, so the industry can move forward together,” commented Sean Soth, Senior Vice President of Strategy & Global Business Partnerships for SCRS. “Site engagement and access is critical to our mission” said Tom Lemberg, founder and CEO of Curebase. “We are excited to work closely with SCRS as a Global Impact Partner to enable access to clinical studies for any clinician, including independent sites, to advance clinical research.” About Curebase Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community. This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News! About The Society for Clinical Research Sites (SCRS) Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

Contact: Marissa Hill SCRS Communications Society for Clinical Research Sites 410.696.5080 communications@myscrs.org Lizzy Feliciano SVP, Marketing H1 407.922.2734lizzy.feliciano@h1.co FOR IMMEDIATE RELEASE H1 Announces Global Impact Partnership with Society for Clinical Research Sites Hanover, MD, January 27, 2022 – The Society for Clinical Research Sites (SCRS) announced today that H1, a pioneer in creating connected ecosystems where data, people, research, and clinical trial intelligence come together to drive the industry forward, has joined its Global Impact Partner (GIP) program. SCRS Global Impact Partners work closely with SCRS to provide ongoing development, feedback, and support of industry initiatives designed to improve the voice, sustainability, and performance of clinical research sites. As a Global Impact Partner (GIP), H1 will align with other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally. “H1 is working to provide better industry insights on health care providers, trial history, and global thought leadership through their digital platform suite,” shared Sean Soth, Vice President of Global Business Partnerships for SCRS. “SCRS is pleased to welcome the H1 team to the Global Impact Partner Program.  Our Global Impact Partner community shares an ongoing priority to build the site voice into the future of digital health and patient care, and we are pleased to include H1 in the work ahead.”  “We are beyond excited for this partnership. H1 works with the industry’s top brands and clinical research teams to revolutionize how clinical trial intelligence is applied and operationalized,” said Ariel Katz, Founder and CEO of H1. “Together with SCRS and their global audience, H1 hopes to advance diversification and efficacy across the clinical trial landscape.”  About H1 H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organization. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. Learn more at https://www.h1.co/  About The Society for Clinical Research Sites SCRS is a global trade organization founded in 2012 which represents over 2,300 research sites, including 30,000 research professionals in 40 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit myscrs-new.local/.

Contact:Marissa HillCommunications ManagerSociety for Clinical Research Sitescommunications@myscrs.org410.696.5080 x150 FOR IMMEDIATE RELEASE Hanover, MD, January 26, 2022 – The Society for Clinical Research Sites has announced the launch of its Diversity Site Solutions Summit, which aims to increase knowledge and best practices of clinical research sites to recruit, engage and retain diverse patient populations. The inaugural Diversity Site Solutions Summit, the first clinical research site-focused diversity conference for the industry, will be held May 20, 2022 at Hilton Austin in Austin, Texas. SCRS is uniquely positioned to host a diversity-focused summit as part of its Diversity Awareness Program, which launched in 2016. The work of this group has gained industry, government, regulatory, and site support and will continue to lead to a better understanding of best practices of sites in working with diverse populations. “Moving the needle in diversity enrollment is critical to future site sustainability and efficient patient care. Including diverse patients in research better reflects the breadth of patients who will be using the drug once it is approved,” said Diana Foster, SCRS Vice President of Special Projects and Diversity Awareness Project Lead. “We are eager to share knowledge and solutions to aide sites in more successfully including diverse patients in clinical trials around the world.” “SCRS is honored to create an innovative and solution-driven program to address the critically important industry-wide need of diversity in clinical research,” said Allyson Small, SCRS Chief Operating Officer. “We are confident that this Summit will be a pivotal opportunity to increase the efficiency and effectiveness of diverse recruitment practices for clinical research sites.” Registration for the 2022 Diversity Site Solutions Summit opens soon. The 2022 Global Oncology Site Solutions Summit will be held the following two days, May 21-22, 2022, at the Hilton Austin. ### About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

Contact:Marissa HillCommunications ManagerSociety for Clinical Research Sitescommunications@myscrs.org410.696.5080 x150 FOR IMMEDIATE RELEASE New Date Announced for 2022 European Site Solutions Summit Hanover, MD, January 24, 2022 – The Society for Clinical Research Sites (SCRS) has announced it will be rescheduling the 2022 European Site Solutions Summit to November 14-15, 2022. The Summit was originally planned to be held March 14-15, 2022, in Lisbon, Portugal. SCRS made the change due to the surge of COVID-19 cases around the world and the resulting impact of stricter travel restrictions. Attendee safety continues to be a priority and moving the date to November should better align with approved travel windows for attendees coming from all parts of the globe. “With the recent number of COVID-19 cases, SCRS feels it is in the best interest of attendees to move the European Summit to later in 2022. We anticipate even more organizations will be able to participate in the valuable conversations shaping the way for innovation in clinical research in November,” said Allyson Small, SCRS Chief Operating Officer. “We are looking forward to reuniting in-person with the European clinical research community to share best practices and forward-thinking solutions to ensure site sustainability.” Registration for the 2022 European Site Solutions Summit is open now. Learn more at https://eusitesolutionssummit.com/  SCRS will continue to monitor all aspects of travel restrictions and regional COVID updates and communicate with its member and partner community accordingly. ### About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

Contact: Marissa Hill Communications Manager Society for Clinical Research Sites communications@myscrs.org 410.696.5080 x150 FOR IMMEDIATE RELEASE Teckro Joins SCRS as Global Impact Partner Hanover, MD, January 19, 2022 – Today, the Society for Clinical Research Sites (SCRS) announced a Global Impact Partnership with Teckro, a clinical trial hub for consistent collaboration between sites and sponsors. As a Global Impact Partner (GIP), Teckro will align with sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful partnerships between industry stakeholders and clinical research sites globally. With this collaboration, Teckro will help SCRS set and pursue strategic initiatives and directly work with clinical trial sites and industry peers to address challenges of clinical trials. “At Teckro we believe that clinical trials, which are often the best possible care for many diseases, must be more accessible to people everywhere. It is the sites and trusted physicians, nurses and other staff who are the heart of clinical research and champion for patients. That’s why we are pleased to partner with SCRS to support this active, vibrant community and to participate in initiatives that will help reduce the burden on sites so they are equipped to manage safer, faster and more efficient clinical trials,” said Gary Hughes, Teckro CEO and co-founder. Sean Soth, Senior VP of Strategy and Global Business Partnerships for SCRS, commented, “Active communication is a critical factor for site success. Teckro is working to make communication among stakeholders easier, providing sites with relevant guidance when they are with patients. As digital innovation continues to evolve for site personnel, tools and ideas for improved communication will make collaboration easier. SCRS is pleased to recognize Teckro’s involvement in the Global Impact Partner program and looks forward to including their contributions and ideas for sites and industry in 2022 and beyond.” Learn more about the partnership in the SCRS Talks podcast interview with Silvina Baudino, Director, Site Engagement at Teckro. ### About TeckroRecognized as one of the fastest growing software companies in the clinical trial market, Teckro transforms the study protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Thousands of investigators and more than 27,000 sites around the world rely on Teckro to execute clinical trials. Teckro works with emerging biotech and global pharmaceutical organizations, including 12 out of the Top 20 companies. The Teckro cloud-based platform supports all therapeutic areas, all phases, and any trial format ranging from traditional in-clinic, decentralized clinical trials, or a hybrid approach. About The Society for Clinical Research Sites Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

Contact SCRS Communications Society for Clinical Research Sites 410.696.5080 communications@myscrs.org FOR IMMEDIATE RELEASE SCRS Reschedules 2022 Global Oncology Site Solutions Summit Hanover, MD, January 13, 2021– The Society for Clinical Research Sites (SCRS) has announced it will be rescheduling the 2022 Global Oncology Site Solutions Summit, originally planned for January 28-29, 2022 in Austin, Texas. The event will now be held May 21-22, 2022. “After thoughtful and extensive discussion with SCRS leadership and our partners in the clinical research industry, SCRS has decided to postpone the event to May 2022,” said SCRS Chief Operating Officer Allyson Small.  “The recent surge in Covid cases has impacted travel approvals for many of our attendees. In addition, we understand the importance of prioritizing the health and safety of the patients our oncology sites service. For these reasons we believe it is in the best interest to move the meeting and give time for the surge to dissipate as we have seen it do in other regions of the world.” The fourth annual Global Oncology Site Solutions Summit aims to increase efficiencies and improve site sustainability among clinical research sites participating in oncology studies. The program will explore topics such as diversity, pediatric drug development, privacy and data, medical device regulation, decentralized trials, wearables, and digital readiness for oncology-specific trials and care. ”While last year’s Global Oncology Summit was held successfully in a virtual environment, we know that the live gathering of sites and partners is preferred,”  continued Small. “The push to May gives us additional opportunity to add more program components and develop an even more robust agenda for our membership.” Registration for the 2022 Global Oncology Site Solutions Summit is open now. Learn more at https://oncologysitesolutionssummit.com/ ### About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.

Contact:SCRS CommunicationsSociety for Clinical Research Sites410.696.5080communications@myscrs.org FOR IMMEDIATE RELEASE Hanover, MD, December 16, 2021 – The Society for Clinical Research Sites (SCRS) has announced it is now accepting submissions for the Christine K. Pierre (CKP) Site Impact Award. In honor of late SCRS founder Christine K. Pierre’s vision and legacy, SCRS created the CKP Site Impact Award to recognize an industry leader who has made an extraordinary contribution to furthering the voice of the clinical research site community. The CKP Site Impact Award is given annually at the Global Site Solutions Summit to one esteemed innovator within the clinical research site industry. The recipients of this award are strong advocates on behalf of the site community and uphold the pillars of SCRS by supporting the education, advocacy, mentorship and connection of clinical research sites. Previous winners include Michele Cameron, Director of Clinical Research at Clearwater Cardiovascular Consultants, David Vulcano, Vice President of Research Compliance and Integrity at HCA Healthcare, and Kay Scroggins, President and CEO of Clinical Trials of Texas. “The CKP Site Impact Award is exceptionally meaningful to SCRS and the clinical research community as we recognize incredible individuals and their contributions to Christine’s mission,” commented Allyson Small, SCRS Chief Operating Officer. “The past recipients of these awards have shown dedication and commitment to ensuring the site voice is heard, and we look forward to honoring Christine Pierre’s legacy through this year’s recipient.” The winner will be selected based on their contributions to the sustainability of the clinical research site community. Any individual that works at an SCRS member site is eligible for nomination. Submissions can be made via the SCRS Global Site Solutions Summit website through August 15, 2022. ### About The Society for Clinical Research SitesFounded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit myscrs-new.local/.